Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Haenni

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Clinical Pharmacology|January 1, 1994
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibitionR Reneland, P E Andersson, A Haenni, et al.
Blood Pressure|July 21, 1999
Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly menR Reneland, A Haenni, P E Andersson, et al.
American Journal of Hypertension|July 1, 1994
Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groupsA Haenni, P E Andersson, L Lind, et al.
Journal of Human Hypertension|August 15, 1998
Insulin resistance in essential hypertension is related to plasma renin activityL Lind, R Reneland, P E Andersson, et al.
Journal of Human Hypertension|March 1, 2000
Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolaprilR Reneland, E Alvarez, P E Andersson, et al.
American Journal of Hypertension|February 1, 1997
The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balanceA Haenni, L Berglund, R Reneland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 27, 2007
Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretionH-E Johansson, M Ohrvall, A Haenni, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Clinical Pharmacology|January 1, 1994
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibitionR Reneland, P E Andersson, A Haenni, et al.
Blood Pressure|July 21, 1999
Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly menR Reneland, A Haenni, P E Andersson, et al.
American Journal of Hypertension|July 1, 1994
Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groupsA Haenni, P E Andersson, L Lind, et al.
Journal of Human Hypertension|August 15, 1998
Insulin resistance in essential hypertension is related to plasma renin activityL Lind, R Reneland, P E Andersson, et al.
Journal of Human Hypertension|March 1, 2000
Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolaprilR Reneland, E Alvarez, P E Andersson, et al.
American Journal of Hypertension|February 1, 1997
The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balanceA Haenni, L Berglund, R Reneland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 27, 2007
Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretionH-E Johansson, M Ohrvall, A Haenni, et al.
Pageof 2